Cytek Biosciences, Inc. CTKB EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s EBITDA?
- Cytek Biosciences, Inc. (CTKB) reported EBITDA of -$16.6M in Q1 2026.
- How has Cytek Biosciences, Inc.'s EBITDA changed year-over-year?
- Cytek Biosciences, Inc.'s EBITDA decreased by 26.7% year-over-year, from -$13.1M to -$16.6M.
- What is the long-term trend for Cytek Biosciences, Inc.'s EBITDA?
- Over 3 years (2021 to 2025), Cytek Biosciences, Inc.'s EBITDA has grown at a 46.7% compound annual growth rate (CAGR), from $10.4M to -$32.81M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.